- 不限
- 乙肝治愈转化医学研究 Translational study for functional cure of chronic HBV infection
- 肝癌及门脉高压治疗 Treatment of liver cancer and portal hypertension
- 肝衰竭、人工肝、重症感染 Liver failure, artificial liver, severe infection
- 肿瘤免疫治疗及转化研究 Tumor Immunotherapy and Translational Research
- 精准医学高峰论坛 Precision Medicine Summit Forum
- 国际消除病毒性肝炎论坛 International Forum on Elimination of Viral Hepatitis
- 新药研发热点 New drug research and development hotspots
- 中法肝病论坛：肝病无创诊断技术最新进展及应用 Sino-French Liver Diseases Forum：Advancement & Application of Non-invasive Diagnostic Technology
- 传染病国家级平台学科建设高峰论坛 National Platform for Discipline Construction of Infectious Diseases Summit Forum
- 介入专场 Intervention Session
- 医防融合：社区和MDT管理培训 Medical and prevention integration: community and MDT management training
- 不限
- 2021-12-10 [星期五]
- 2021-12-11 [星期六]
- 2021-12-12 [星期日]
- 不限
- 主会场（大沙龙厅） The Main Venue（Dashalong Hall）
- 大沙龙厅1 Dashalong Hall 1
- 大沙龙厅2 Dashalong Hall 2
- 大沙龙厅3 Dashalong Hall 3
2021-12-10 星期五
大沙龙厅2 Dashalong Hall 2
| 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|
| 10:00-10:30 |
生发中心免疫反应在乙肝治愈中的免疫调节作用 |
李咏茵 | 南方医科大学南方医院 |
|
Immunoregulatory Functions of Germinal Center Responses in Hepatitis B Cure |
Yongyin Li | Nanfang Hospital, Southern Medical University | |
| 10:30-11:00 |
《中国慢乙肝防治指南》更新看乙肝治愈 |
杨晴 | 珠海市人民医院 |
|
Updated View of Hepatitis B Cure in the Guidelines for Prevention and Treatment of Chronic Hepatitis B in China |
Qing Yang | Zhuhai People's Hospital | |
| 11:00-11:30 |
HBsAg定量检测对慢乙肝抗病毒治疗停药的临床意义 |
周晓蕾 | 珠海市人民医院 |
|
The Clinical Significance of the HBsAg Quantitative Detection in Chronic Hepatitis B Patients fter Antiviral Therapy Withdrawal |
Xiaolei Zhou | Zhuhai People's Hospital | |
| 11:30-12:00 |
基于免疫调节策略的乙肝治愈新靶点的发现与开发应用 |
张小勇 | 南方医科大学南方医院 |
|
The New Target for Hepatitis B Cure Based on Immunoregulatory Strategies: Development and Application |
Xiaoyong Zhang | Nanfang Hospital, Southern Medical University |
| 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|
| 14:30-14:50 |
PRAK在肿瘤转移中的关键作用及其潜在的临床应用 |
张毓 | 锦州医科大学 |
|
Key role of PRAK in tumor metastasis and its potential clinical application |
Yu Zhang | Life Science Institute of Jinzhou Medical University | |
| 14:50-15:10 |
靶向Nectin4/NKG2DL/FAP的超能Hi-TCR-T细胞对肝癌等实体肿瘤的临床试验研究 |
高基民 | 温州医科大学 |
|
Clinical trial study of super-powered Hi-TCR-T cells targeting Nectin4/NKG2DL/FAP on liver cancer and other solid tumors |
Jimin Gao | Wenzhou Medical University | |
| 15:10-15:30 |
肿瘤细胞免疫治疗新思路和新进展 |
罗荣城 | 广州中医药大学金沙洲医院 |
|
New ideas and progress in tumor cell immunotherapy |
Rongcheng Luo | TCM-Integrated Cancer Center of Southern Medical University | |
| 15:30-15:50 |
γδT细胞治疗的临床应用与未来 |
尹芝南 | 暨南大学生物医学转化研究院 |
|
Clinical application and the future of γδT cell therapy |
Zhinan Yin | Jinan University |
| 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|
| 16:10-16:30 |
从豪猪信号通路的分子靶点到肝癌的辅助诊断 |
吴健 | 复旦大学基础医学院 |
| Jian Wu | Zhongshan Hospital Red Cross Hospital | ||
| 16:30-16:50 |
肝脏再生过程中基因调节网络的时空动态变化 |
Miguel A. Esteban | Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences |
|
Spatio-temporal dynamics of gene regulation during liver regeneration |
Miguel A. Esteban | Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences | |
| 16:50-17:10 |
HBV感染和HBV相关HCC的个体化T细胞治疗 |
Antonio Bertoletti | 新加坡杜克大学 |
|
Personalized T cell therapy in HBV infection and HBV-related HCC |
Antonio Bertoletti | Duke-NUS Medical School, Singapore | |
| 17:10-17:30 |
治愈HBV的免疫疗法的机遇和挑战 |
Ulrike Protzer | 德国慕尼黑亥姆霍兹中心和慕尼黑工业大学病毒研究院 |
|
Opportunities and challenges of immunotherapeutic approaches of HBV cure |
Ulrike Protzer | Institute of Virology, Technical University of Munich, Germany |
美迪康会务通